Accuray Incorporated (ARAY) is a publicly traded Healthcare sector company. As of May 21, 2026, ARAY trades at $0.31 with a market cap of $34.82M and a P/E ratio of -0.86. ARAY moved +15.01% today. Year to date, ARAY is -62.47%; over the trailing twelve months it is -80.88%. Its 52-week range spans $0.25 to $2.95. Analyst consensus is neutral with an average price target of $0.35. Rallies surfaces ARAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Accuray Q3 Revenue Falls 7% to $104.8M, Guidance Withdrawn: Accuray posted fiscal Q3 net revenue of $104.8 million, a 7% decline, and recorded a net loss of $11.8 million ($0.09 per share) with gross margin slipping to 24.1%. The company realized $10 million in transformation-driven cost improvements but withdrew FY26 guidance due to Middle East delays.
| Metric | Value |
|---|---|
| Price | $0.31 |
| Market Cap | $34.82M |
| P/E Ratio | -0.86 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.95 |
| 52-Week Low | $0.25 |
| Volume | 207.79K |
| Avg Volume | 0 |
| Revenue (TTM) | $428.57M |
| Net Income | $-46.13M |
| Gross Margin | 26.92% |
2 analysts cover ARAY: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.35.